However, HR-deficient cells lacking BRCA1 or BRCA2 show specific susceptibility to PARP1 inhibition, whereby accumulation of genetic lesions and ensuing chromosome instability in fast-dividing cancer cells results in their death [4, 5]. The gene discussed is PARP1; the disease is cancer.